Delivery Order SPE2DB22D9316-SPE2DB25FYP73
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $43.3K for ICLUSIG 30 mg tablets (30-count units) from the Medical Supply Chain, a defense-focused federal agency. This award, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, is a firm fixed-price delivery order with no set-aside designation. The contract represents a single award under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $171,788.80 on August 20, 2025, for the supply of Iclusig 30 mg tablets (30-count packages). The contract, with an ultimate completion date of September 11, 2025, is funded through the Defense Logistics Agency's Medical Supply Chain program and carries no set-aside designation. This delivery order is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $42,592.16 for the supply of Iclusig 15 mg tablets (30-count units) by the Defense Logistics Agency on March 12, 2025. This firm fixed-price delivery order, with an ultimate completion date of April 2, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $21,735.58 firm fixed-price delivery order is for the supply of ICLUSIG 30 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of October 1, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $21,735.58 firm fixed-price delivery order is for the supply of ICLUSIG 30 MG TABLET 30S, a pharmaceutical product, with a performance period running through December 3, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $19,565.14 by the Defense Logistics Agency to provide 4563163808 ICLUSIG 45 MG TABLET 30S. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceutical items and medical products with a potential value of up to $5 million through December 2025. As a woman-owned small business and pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $64,953.36 contract is for the delivery of ICLUSIG 30 MG TABLET 30S, a prescription medication, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $42,592.16 by the Defense Logistics Agency (DLA) on July 14, 2025, with an ultimate completion date of August 4, 2025. The delivery order, contract number 4568823267, covers the supply of Iclusig 15 mg tablets (30-count units), a specialty oncology medication. This award was issued without a set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $41,870.16 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of ICLUSIG 15 MG TABLET 30S, a pharmaceutical product, with a period of performance through April 10, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery vehicle (IDV) contract 4600082013 with DLA, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $41,870.16 firm-fixed-price delivery order is for the supply of ICLUSIG 45 MG TABLET 30S, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide range of...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB25FYP73Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $42,891.80 by the Defense Logistics Agency on August 7, 2025, for the supply of ICLUSIG 45 mg tablets (30-count units). The contract, which carries no set-aside designation, is scheduled for completion by August 28, 2025, and represents a targeted pharmaceutical delivery to support federal healthcare operations. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities nationwide. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its established position to distribute branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. ICLUSIG, a specialty oncology medication, exemplifies the company's portfolio of high-value pharmaceutical products serving military medical supply needs. The delivery order structure allows the Defense Logistics Agency to efficiently procure specific pharmaceutical items as needed while maintaining cost certainty through firm fixed pricing, supporting the agency's mission to supply medical resources across defense healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.9k | 8/7/25 |